http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109576374-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109576374-B |
| titleOfInvention | Application of circ-FAM193A molecular marker in blood in diagnosis and prognosis of esophageal squamous cell carcinoma |
| abstract | The invention belongs to the field of tumor molecular biology, and particularly relates to an application of a circ-FAM193A molecular marker in blood in diagnosis and prognosis of esophageal squamous cell carcinoma, wherein a detection reagent of the circ-FAM193A molecular marker can be used for preparing a diagnostic reagent of the esophageal squamous cell carcinoma; the circular RNA has the characteristics of stable mechanism, high abundance and sample specific expression, and the expression quantity of the circ-FAM193A in blood samples of ESCC patients and normal people is different and related to stages, so that the method is easily accepted by examinees and can become an effective means for early diagnosis and disease progress judgment of the ESCC patients. |
| priorityDate | 2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 176.